SCHEMBL3134024

SCHEMBL3134024

CCOC(=O)c1sc(N)c(C#N)c1-c1ccc(-c2ccccc2SC)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 2/20 0.52
GRIA2 P42262 1/20 0.52
FNTA P49354 12/20 0.51
FNTB P49356 12/20 0.51
L3MBTL1 Q9Y468 2/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
BRCA1 P38398 1/20 0.46
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138668 0.88 GRIA4 (0.54) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3138502 0.88 FNTA (0.53) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3135036 0.87 L3MBTL1 (0.51) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3128939 0.86 GRIA4 (0.50) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3128662 0.83 FNTA (0.57) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3128242 0.81 L3MBTL1 (0.56) FNTAFNTBL3MBTL1MEN1KMT2A
SCHEMBL3136646 0.80 FNTA (0.58) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3143105 0.80 GRIA4 (0.56) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL5731679 0.78 FNTA (0.48) GRIA4GRIA2FNTAFNTBL3MBTL1
SCHEMBL3139129 0.78 FNTA (0.63) GRIA4GRIA2FNTAFNTBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-7642361-B2 Thiophene and furan compounds ELI LILLY AND COMPANY (US) 2010-01-05 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
US-20070105852-A1 Thiophene and furan compounds ELI LILLY AND COMPANY 2007-05-10 US disclosed
EP-1706395-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2006-10-04 EP disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105852-A1 Thiophene and furan compounds PSEN2, PSEN1, TPMT GRIA4 15/4885GRIA2 57/4885FNTA 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.